SUBSTITUTED HETEROARYL COMPOUNDS AND METHODS OF USE
申请人:Xi Ning
公开号:US20170081338A1
公开(公告)日:2017-03-23
The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.